NewsnReleases

Financial news, corporate announcements, analysts’ reports

investor news

  • Global Corporate Acquisition Announcements from Equity Markets: What Investors Need to Know

    Global Corporate Acquisition Announcements from Equity Markets: What Investors Need to Know

    •

    Bernice Miles

    In today’s fast-moving financial landscape, staying on top of global corporate acquisition announcements from equity markets is no longer a luxury — it’s a necessity. Whether you’re a portfolio manager in London, a retail investor in Singapore, or an analyst tracking deal flow in New York, the pace of corporate consolidation across the world’s…

  • Credit Corp reports strong recovery, optimistic outlook for FY26

    •

    NNR

    Company’s net profit for FY25 reached $94.1 million, which is a 16% increase over the previous year SYDNEY: Credit Corp Group Limited (ASX: CCP), a provider of debt purchasing and consumer lending services, announced a solid recovery for the 2025 financial year (FY25) and presented a strong outlook for FY26. The company’s net profit…

  • Alibaba announces HK$12 billion exchangeable bond offering linked to Alibaba Health

    •

    NNR

    HONG KONG: Alibaba Group Holding Limited (NYSE: BABA; HKEX: 9988, 89988) on Thursday unveiled plans for a HK$12 billion offering of zero coupon exchangeable bonds, linked to the ordinary shares of Alibaba Health Information Technology Limited (HKEX: 00241). The private placement is aimed at certain non-U.S. investors under Regulation S of the U.S. Securities…

  • TALi Digital acquires You Can Do It! Education

    •

    NNR

    MELBOURNE: TALi Digital Ltd (ASX: TD1), a digital health company, has announced the acquisition of You Can Do It! Education (YCDI!), a social-emotional learning program, for $1.34 million. The deal, funded by TALi’s existing cash reserves, includes an upfront payment of $1.14 million and $200,000 in installments over 24 months. YCDI!, an Australian-based program,…

  • N4 Pharma reports 2024 financial results

    •

    NNR

    LONDON: N4 Pharma plc (AIM: N4P), a UK-based biotechnology company developing its proprietary Nuvec® gene delivery system for advanced cancer and disease therapies, announced its audited financial results for the year ended Dec. 31, 2024. The company’s annual report and notice of its annual general meeting (AGM) have been distributed to shareholders. The AGM…

Exit mobile version